The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: towards a biologically-based screening strategy.
Both benign and malignant prostate diseases elevate total prostate-specific antigen (tPSA), and the incidence of benign disease increases markedly with age. There is evidence, however, that free-to-total PSA ratio (%fPSA) and human kallikrein 2 (hK2) more closely reflect the malignant process. We te...
Үндсэн зохиолчид: | Vickers, A, Ulmert, D, Serio, A, Björk, T, Scardino, P, Eastham, J, Berglund, G, Lilja, H |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2007
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population.
-н: Ulmert, D, зэрэг
Хэвлэсэн: (2008) -
Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study.
-н: Ulmert, D, зэрэг
Хэвлэсэн: (2008) -
Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.
-н: Lilja, H, зэрэг
Хэвлэсэн: (2007) -
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.
-н: Vickers, A, зэрэг
Хэвлэсэн: (2010) -
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: Case-control study
-н: Vickers, A, зэрэг
Хэвлэсэн: (2010)